Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
161,976,581
-
Total 13F shares
-
167,058,080
-
Share change
-
-1,269,854
-
Total reported value
-
$1,902,580,964
-
Put/Call ratio
-
2.8%
-
Price per share
-
$11.39
-
Number of holders
-
187
-
Value change
-
-$2,007,043
-
Number of buys
-
94
-
Number of sells
-
83
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q4 2020
As of 31 Dec 2020,
IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) was held by
187 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
167,058,080 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, BROWN CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, Sarissa Capital Management LP, BlackRock Inc., WESTFIELD CAPITAL MANAGEMENT CO LP, STATE STREET CORP, Camber Capital Management LP, PUTNAM INVESTMENTS LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
187
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.